摘要
目的探讨尿流率测定对前列腺增生治疗效果的评价作用。方法前列腺增生患者246例,其中89例接受前列腺等离子电切术(手术组),157例接受药物治疗(药物组),测定两组治疗前后最大尿流率(Qmax)、平均尿流率(Qave)、尿流时间。结果与治疗前比较,两组患者治疗后1个月的Qmax、Qave均明显增加(P<0.01),尿流时间明显减少(P<0.01),以手术组更为显著(P<0.01)。结论尿流率测定可作为评价保守治疗与等离子电切术治疗后疗效重要的客观指标。
Objective To explore the effect of uroflowmetry in the evaluation of curative effect for benign prostatic hyperplasia. Methods246 patients with benign prostatic hyperplasia were included in the study, of which 89 patients received prostate plasma resection（Operation Group） and 157 patients received drug therapy（Drug Group）. The maximum urine flow rate（Qmax）, average urine flow rate（Qave） and urine flow time（T） of the two groups were measured before and after treatment. Compared with those before treatment, the Qmax and Qave in the two groups increased significantly Results1 month after the treatment（P〈0.01） and T decreased in the two groups significantly（P〈0.01） 1 month after the treatment, which the Operation Group showed a more significant change（P〈0.01）. Conclusion Uroflowmetry can be used as an objective index to evaluate the efficacy of conservative treatment and plasma resection.
作者
刘雷
黄星华
李逊
陈楚义
李坚伟
陈统权
周建华
LIU Lei;HUANG Xing-hua;LI Xun;CHEN Chu-yi;LI Jian-wei;CHEN Tong-quan;ZHOU Jian-hua(Longgang People＇s Hospital of Shenzhen,Shenzhen 518172,China;The Fifth Affiliated Hospital of Guangzhou Medical University,Guangzhou 510799,China)
出处
《广东医科大学学报》
2018年第4期435-437,共3页
Journal of Guangdong Medical University
